(1)
Blauvelt, A. .; Iversen, L.; McBride, S. .; Gooderham, M.; Staubach, P.; Yamauchi, P.; Staelens, F.; Vanoorden, V.; White, K. .; Gisondi, P. Bimekizumab Versus Secukinumab Efficacy across Subgroups of Patients With Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3b BE RADIANT Trial. J of Skin 2021, 5, s53.